News

October 3, 2023

AffyImmune Therapeutics to Present at 2023 Cell & Gene Meeting on the Mesa

September 21, 2023

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance

September 21, 2023

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance

September 21, 2023

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance

May 31, 2023

ASCO 2023 Poster

May 25, 2023

AffyImmune Therapeutics Announces Positive Safety and Early Efficacy Results from Phase 1 Study of AIC100 CAR T Cells in Anaplastic and Advanced Thyroid Cancers at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting